Literature DB >> 11264425

Is periventricular leukomalacia an axonopathy as well as an oligopathy?

O Dammann1, H Hagberg, A Leviton.   

Abstract

Periventricular leukomalacia is a white matter disorder, the neonatal cranial ultrasound images of which predict long-term developmental limitations among preterm infants. The vulnerability of oligodendrocytes has led to the hypothesis that oligodendrocytes suffer the primary damage, with axonal damage occurring as a consequence. In this article, we discuss the differential role of oligodendrocytes and axons in this disorder's etiology, offering analogies from the multiple sclerosis and hydrocephalus literature. We conclude that it is too early to view periventricular leukomalacia exclusively as a consequence of oligodendrocyte damage and/or maldevelopment.

Entities:  

Mesh:

Year:  2001        PMID: 11264425     DOI: 10.1203/00006450-200104000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  20 in total

1.  Differential susceptibility to axonopathy in necrotic and non-necrotic perinatal white matter injury.

Authors:  Art Riddle; Jennifer Maire; Xi Gong; Kevin X Chen; Christopher D Kroenke; A Roger Hohimer; Stephen A Back
Journal:  Stroke       Date:  2011-11-10       Impact factor: 7.914

2.  Structural, immunocytochemical, and mr imaging properties of periventricular crossroads of growing cortical pathways in preterm infants.

Authors:  Milos Judas; Marko Rados; Natasa Jovanov-Milosevic; Pero Hrabac; Ranka Stern-Padovan; Ivica Kostovic
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

3.  Developmental changes in diffusion anisotropy coincide with immature oligodendrocyte progression and maturation of compound action potential.

Authors:  Alexander Drobyshevsky; Sheng-Kwei Song; Georgi Gamkrelidze; Alice M Wyrwicz; Matthew Derrick; Fan Meng; Limin Li; Xinhai Ji; Barbara Trommer; Douglas J Beardsley; Ning Ling Luo; Stephen A Back; Sidhartha Tan
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

Review 4.  Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina.

Authors:  Charanjit Kaur; Gurugirijha Rathnasamy; Eng-Ang Ling
Journal:  J Neuroimmune Pharmacol       Date:  2012-02-26       Impact factor: 4.147

5.  In vivo magnetization transfer MRI shows dysmyelination in an ischemic mouse model of periventricular leukomalacia.

Authors:  Ali Fatemi; Mary Ann Wilson; Andre W Phillips; Michael T McMahon; Jiangyang Zhang; Seth A Smith; Edwin J Arauz; Sina Falahati; Abhijeet Gummadavelli; Hima Bodagala; Susumu Mori; Michael V Johnston
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-04       Impact factor: 6.200

6.  Premyelinated central axons express neurotoxic NMDA receptors: relevance to early developing white-matter injury.

Authors:  Tahani Huria; Narasimha Murthy Beeraka; Badrah Al-Ghamdi; Robert Fern
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

Review 7.  Fetal inflammatory response and brain injury in the preterm newborn.

Authors:  Shadi Malaeb; Olaf Dammann
Journal:  J Child Neurol       Date:  2009-07-15       Impact factor: 1.987

8.  Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin.

Authors:  Robin L Haynes; Saraid S Billiards; Natalia S Borenstein; Joseph J Volpe; Hannah C Kinney
Journal:  Pediatr Res       Date:  2008-06       Impact factor: 3.756

9.  Anatomical characterization of athetotic and spastic cerebral palsy using an atlas-based analysis.

Authors:  Shoko Yoshida; Andreia V Faria; Kenichi Oishi; Toyoko Kanda; Yuriko Yamori; Naoko Yoshida; Haruyo Hirota; Mika Iwami; Sozo Okano; John Hsu; Xin Li; Hangyi Jiang; Yue Li; Katsumi Hayakawa; Susumu Mori
Journal:  J Magn Reson Imaging       Date:  2013-06-04       Impact factor: 4.813

Review 10.  The roles of neuron-NG2 glia synapses in promoting oligodendrocyte development and remyelination.

Authors:  Rongrong Li; Pu Zhang; Mao Zhang; Zhongxiang Yao
Journal:  Cell Tissue Res       Date:  2020-03-31       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.